Loading clinical trials...
Loading clinical trials...
Carbapenem-Resistant Enterobacteriaceae (CRE) are bacteria that have become resistant to carbapenems by producing enzymes that break down carbapenems. The prevalence of CRE continues to rise globally ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of California, Los Angeles
Collaborators
NCT03325855 · Fecal Microbiota Transplantation, Clostridium Difficile Infection, and more
NCT05632315 · Multidrug Resistant Bacterial Infection, Enterobacteriaceae Infections, and more
NCT05790356 · Arthritis, Arthritis, Rheumatoid, and more
NCT06205862 · Fecal Microbiota Transplantation, Colorectal Adenoma, and more
NCT01790061 · Bacteria, Microbiota, and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions